Physician

Swapna Kamadana, M.D.

According to 2025 Medicare claims, Swapna Kamadana, M.D. (NPI: 1356565048) practices nephrology in the Mansfield, OH market, with the plurality of this provider's patient population coming from Richland, OH. This provider's primary affiliated billing organization is KIDNEY ASSOCIATES, INC. (NPI: 1851348304; TIN: 341346017) and primary practice location at 44903-2269. Kamadana is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Kamadana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 655 traditional Medicare patients, billed 2,122 HCPCS/CPT codes, and received $198,696 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,962 prescription claims across 316 beneficiaries totaling $220,176 in drug costs, led by Auryxia (Ferric Citrate). 2021 DME data shows 22 claims. Open Payments data shows 3 records totaling $77. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $296,578 to $220,176. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	774	2,540	$255,033
2016	904	2,928	$276,609
2017	881	2,948	$291,566
2018	923	3,256	$365,167
2019	950	3,283	$325,585
2020	971	3,540	$328,800
2021	947	3,308	$321,763
2022	827	2,955	$285,638
2023	692	2,208	$215,720
2024	655	2,122	$198,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	231	1,594	$296,578
2016	304	2,271	$434,293
2017	347	3,066	$725,291
2018	379	3,199	$437,876
2019	379	2,977	$367,223
2020	327	2,612	$293,843
2021	322	2,209	$257,854
2022	310	2,019	$256,414
2023	313	1,985	$321,606
2024	316	1,962	$220,176

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$274
2016	N/R	68	$2,737
2017	N/R	35	$1,874
2018	N/R	25	$437
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	22	$368
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	142	153	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	154	209	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	193	443	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	123	135	$55
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	144	275	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Auryxia	Ferric Citrate	55	2,250	$66,763
Velphoro	Sucroferric Oxyhydroxide	32	1,200	$53,428
Sevelamer Carbonate	Sevelamer Carbonate	109	4,547	$16,783
Midodrine Hcl	Midodrine Hcl	25	2,040	$3,115
Calcitriol	Calcitriol	243	17,502	$2,990

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$77	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Swapna Kamadana, M.D.?

Tedicare shows public-source Medicare data for Swapna Kamadana, M.D. (NPI 1356565048), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Swapna Kamadana, M.D. have ACO affiliation data?

Swapna Kamadana, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Swapna Kamadana, M.D.?

Swapna Kamadana, M.D. is linked to KIDNEY ASSOCIATES, INC. (billing NPI 1851348304) in the available physician profile data.

Does Swapna Kamadana, M.D. have Open Payments data?

Swapna Kamadana, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.